Peroxidase-catalyzed pro- versus antioxidant effects of 4- hydroxytamoxifen: Enzyme specificity and biochemical sequelae

Chemical Research in Toxicology

Volumn 12, Issue 1, 1999, Pages 28-37

  Day, Billy W ^a   Tyurin, Vladimir A ^b   Tyurina, Yulia Y ^b   Liu, Mei ^c   Facey, Judy A ^c   Carta, Gianfranca ^c   Kisin, Elena R ^c   Dubey, Raghvendra K ^c   Kagan, Valerian E ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; DROLOXIFENE; GLUTATHIONE; MEMBRANE PHOSPHOLIPID; PEROXIDASE; PHENOL; TAMOXIFEN;

ANTIOXIDANT ACTIVITY; ARTICLE; CATALYSIS; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME SPECIFICITY; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; LIPID OXIDATION; OXIDATION REDUCTION REACTION; REACTION ANALYSIS;

ANIMALS; ANTIOXIDANTS; AORTA; CELL SURVIVAL; CELLS, CULTURED; ESTROGEN ANTAGONISTS; FATTY ACIDS; GLUTATHIONE; HL-60 CELLS; HUMANS; LIPID PEROXIDATION; MUSCLE, SMOOTH, VASCULAR; OXIDANTS; OXIDATION-REDUCTION; PEROXIDASE; PEROXIDASES; PHENOL; PHOSPHOLIPIDS; RATS; SERUM ALBUMIN; TAMOXIFEN;

EID: 0032912983     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980137r     Document Type: Article

References (44)

1. Wiseman, H., Laughton, M. J., Arnstein, H. R., Cannon, M., and Halliwell, B. (1990) The antioxidant action of tamoxifen and its metabolites. Inhibition of lipid peroxidation. FEBS Lett. 263, 192-194.
2. Wiseman, H. (1994) Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances. Trends Pharmacol. Sci. 15, 83-89.
3. Custodio, J. B., Dinis, T. C., Almeida, L. M., and Madeira, V. M. (1994) Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity. Biochem. Pharmacol. 47, 1989-1998.
4. Wiseman, H., Rice-Evans, C., and Halliwell, B. (1994) Antioxidant benefits of tamoxifen therapy for breast cancer? Breast Cancer Res. Treat. 29, 307.
5. Wiseman, H., and Quinn, P. (1994) The antioxidant action of synthetic oestrogens involves decreased membrane fluidity: relevance to their potential use as anticancer and cardioprotective agents compared to tamoxifen? Free Radical Res. 21, 187-194.
6. Wiseman, H. (1995) Tamoxifen as an antioxidant and cardioprotectant. Biochem. Soc. Symp. 61, 209-219.
7. Fisher, B., Costantino, J. P., Redmond, C. K., Fisher, E. R., Wicherham, D. L., and Cronin, W. M. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl. Cancer Inst. 86, 527-537.
8. van Leeuwen, F. E., Benraadt, J., Coebrgh, J. W., Kiemeny, L. A., Gimbrere, C. H., Otter, R., Schouten, L. J., Damhuis, R. A., Bontenbal, M., Diepenhorst, F. W., van den Belt-Dusebout, A. W., and van Tinteren, H. (1994) Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343, 448-452.
9. Fisher, B. (1996) Commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients. J. Clin. Oncol. 14, 1027-1039.
10. Cuenca, R. E., Giachinno, J., Arredondo, M. A., Hempling, R., and Edge, S. B. (1996) Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use. Cancer 77, 2058-2063.
11. Stearns, V., and Gelmann, E. P. (1998) Does tamoxifen cause cancer in humans? J. Clin. Oncol. 16, 779-792.
12. Vancutsem, P. M., Lazarus, P., and Williams, G. M. (1994) Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen. Cancer Res. 54, 3864-3867.
13. Han, X. L., and Liehr, J. G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res. 52, 1360-1363.
14. Pathak, D. N., Pongracz, K., and Bodell, W. J. (1995) Microsomal and peroxidase activation of 4-hydroxytamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen. Carcinogenesis 16, 11-15.
15. Dehal, S. S., and Kupfer, D. (1996) Evidence that the catechol 3,4-dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins. Cancer Res. 56, 1283-1290.
16. Crofton-Sleigh, C., Doherty, A., Ellard, S., Parry, E. M., and Venitt, S. (1993) Micronucleus assays using cytochalasin-blocked MCL-5 cells, a proprietary human cell line expressing five human cytochromes P-450 and microsomal epoxide hydrolase. Mutagenesis 8, 363-372.
17. Sargent, L. M., Dragan, Y. P., Bahnub, N., Wiley, J. E., Sattler, C. A., Schroeder, P., Sattler, G. L., Jordan, V. C., and Pitot, H. C. (1994) Tamoxifen induces hepatic aneuploidy and mitotic spindle disruption after a single in vivo administration to female Sprague-Dawley rats. Cancer Res. 54, 3357-3360.
18. Davies, A. M., Martin, E. A., Jones, R. M., Lim, C. K., Smith, L. L., and White, I. N. (1995) Peroxidase activation of tamoxifen and toremifene resulting in DNA damage and covalently bound protein adducts. Carcinogenesis 16, 539-545.
19. Pathak, D. N., Pongracz, K., and Bodell, W. J. (1996) Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen. Carcinogenesis 17, 1785-1790.
20. Carmichael, P. L., Ugwumadu, A. H. N., Neven, P., Hewer, A. J., Poon, G. K., and Phillips, D. H. (1996) Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res. 56, 1475-1479.
21. Smith, M. T. (1996) The mechanism of benzene induced leukemia: A hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 104 (Suppl. 6), 1219-1225.
22. Tsutsui, T., and Barrett, J. C. (1997) Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals. Environ. Health Perspect. 105 (Suppl. 3), 619-624.
23. Dubey, R. K., Roy, A., and Overbeck, H. W. (1992) Culture of renal arteriolar smooth muscle cells: mitogenic responses to angiotensin II. Circ. Res. 71, 1143-1152.
24. Nonaka, T., Mio, M., Doi, M., and Tasaka, K. (1992) Histamine-induced differentiation of HL60 cells. The role of cAMP and protein kinase A. Biochem. Pharmacol. 44, 1115-1121.
25. Ritov, V. B., Banni, S., Yalowich, J. C., Day, B. W., Claycamp, H. G., Corongiu, F. P., and Kagan, V. E. (1996) Non-random peroxidation of different classes of membrane phospholipids in live cells detected by metabolically integrated cis-parinaric acid. Biochim. Biophys. Acta 1283, 127-140.
26. Geurts van Kessel, W. S. M., Hax, W. M. A., Demel, R. A., and DeGier, J. (1977) High performance liquid chromatographic separation and direct ultraviolet detection of phospholipids. Biochim. Biophys. Acta 486, 524-530.
27. Chalvardjian, A., and Rudnicki, E. (1970) Determination of lipid phosphorous in the nanomolar range. Anal. Biochem. 36, 225-226.
28. Stoyanovsky, D. A., Goldman, R., Jonnalagadda, S. S., Day, B. W., Claycamp, H. G., and Kagan, V. E. (1996) Identification of the electron paramagnetic resonance-silent glutathionyl-5,5-dimethyl-1-pyrroline N-oxide adduct derived from redox cycling of phenoxyl radicals in model systems and HL60 cells. Arch. Biochem. Biophys. 330, 3-11.
29. Ellman, G. L. (1959) Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70-77.
30. Kagan, V. E., Yalowich, J. C., Day, B. W., Goldman, R., Gantchev, T. G., and Stoyanovsky, D. A. (1994) Ascorbate is the primary reductant of the phenoxyl radical of etoposide in the presence of thiols both in cell homogenates and in model systems. Biochemistry 33, 9651-9660.
31. Ramakrishna Rao, D. N., Fischer, V., and Mason, R. P. (1990) Glutathione and ascorbate reduction of the acetaminophen radical formed by peroxidase. Detection of the glutathione disulfide radical anion and the ascorbyl radical. J. Biol. Chem. 265, 844-847.
32. Niki, E. (1990) Free radical initiators as source of water- or lipid-soluble peroxyl radicals. Methods Enzymol. 186, 100-108.
33. Siegfried, J. M., Nelson, K. G., Martin, J. L., and Kaufman, D. G. (1984) Histochemical identification of cultured cells from human endometrium. In Vitro 20, 25-32.
34. Demers, L. M., Rees, M. C., and Turnbull, A. C. (1984) Arachidonic acid metabolism by the non-pregnant human uterus. Prostaglandins, Leukotrienes Med. 14, 175-180.
35. Rees, M. C., Parry, D. M., Anderson, A. B., and Turnbull, A. C. (1982) Immunohistochemical localisation of cyclooxygenase in the human uterus. Prostaglandins 23, 207-214.
36. Stearns, V., and Gelmann, E. P. (1998) Does tamoxifen cause cancer in humans? J. Clin. Oncol. 16, 779-792.
37. Okada, H., Nawa, M., and Kimura, J. (1985) In vitro effect of estrogens on the peroxidase activity of human endometrium. J. Clin. Endocrinol. Metab. 61, 404-407.
38. Stoyanovsky, D. A., Goldman, R., Claycamp, H. G., and Kagan, V. E. (1995) Phenoxyl radical-induced thiol-dependent generation of reactive oxygen species: implications for benzene toxicity. Arch. Biochem. Biophys. 317, 315-323.
39. Schreiber, J., Foureman, G. L., Hughes, M. F., Mason, R. P., and Eling, T. E. (1989) Detection of glutathione thiyl free radical catalyzed by prostaglandin H synthase in keratinocytes. Study of co-oxidation in a cellular system. J. Biol. Chem. 264, 7936-7943.
40. Maples, K. R., Kennedy, C. H., Jordan, S. J., and Mason, R. P. (1990) In vivo thiyl free radical formation from hemoglobin following administration of hydroperoxides. Arch. Biochem. Biophys. 277, 402-409.
41. Ye, Q. P., and Bodell, W. J. (1996) Production of 8-hydroxy-2′-deoxyguanosine in DNA by microsomal activation of tamoxifen and 4-hydroxytamoxifen. Carcinogenesis 17, 1747-1750.
42. Davies, A. M., Malone, M. E., Martin, E. A., Jones, R. M., Jukes, R., Lim, C. K., Smith, L. L., and White, I. N. (1997) Peroxidase activation of 4-hydroxytamoxifen to free radicals detected by EPR spectroscopy. Free Radical Biol. Med. 22, 423-431.
43. Zeng, J., and Fenna, R. E. (1992) X-ray crystal structure of canine myeloperoxidase at 3 Å resolution. J. Mol. Biol. 226, 185-207.
44. Gajhede, M., Schuller, D. J., Henriksen, A., Smith, A. T., and Poulos, T. L. (1997) Crystal structure of horseradish peroxidase C at 2.15 Å resolution. Nat. Struct. Biol. 4, 1032-1038.